You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 7, 2025

List of Excipients in API diclofenac sodium/misoprostol


✉ Email this page to a colleague

« Back to Dashboard


Excipients in ANDA-approved (generic) drugs containing diclofenac sodium/misoprostol

Detailed excipient profiles for diclofenac sodium/misoprostol

Excipient focus: CELLULOSE, MICROCRYSTALLINE

diclofenac sodium/misoprostol drug variants not containing CELLULOSE, MICROCRYSTALLINE

CompanyIngredientNDC
No data available in table
>Company>Ingredient>NDC

Subscribe to access the full database, or Try for Free

Showing 0 to 0 of 0 entries

Excipient focus: CROSPOVIDONE

Excipient focus: HYDROGENATED CASTOR OIL

Excipient focus: HYPROMELLOSE

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER

diclofenac sodium/misoprostol drug variants not containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER

CompanyIngredientNDC
No data available in table
>Company>Ingredient>NDC

Subscribe to access the full database, or Try for Free

Showing 0 to 0 of 0 entries

Excipient focus: POVIDONE

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: STARCH, CORN

Excipient focus: TALC

Excipient focus: TRIETHYL CITRATE

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group